Published in Biol Psychiatry on October 15, 2000
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46
Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A (2003) 3.29
The brain reward circuitry in mood disorders. Nat Rev Neurosci (2013) 3.08
Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A (2001) 3.01
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci (2011) 2.82
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology (2011) 2.79
Brain on stress: how the social environment gets under the skin. Proc Natl Acad Sci U S A (2012) 2.77
The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron (2013) 2.59
The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci (2004) 2.43
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26
Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression. Psychol Bull (2008) 2.24
Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry (2008) 2.14
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry (2013) 1.92
Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci (2005) 1.67
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord (2009) 1.62
Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry (2008) 1.58
Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry (2008) 1.42
Neuroinflammation and psychiatric illness. J Neuroinflammation (2013) 1.42
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
The bright side of being blue: depression as an adaptation for analyzing complex problems. Psychol Rev (2009) 1.28
Striatum-based circuitry of adolescent depression and anhedonia. J Am Acad Child Adolesc Psychiatry (2013) 1.24
Bipolar disorder: from genes to behavior pathways. J Clin Invest (2009) 1.24
Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry (2002) 1.22
Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology (Berl) (2008) 1.21
Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx (2006) 1.19
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res (2008) 1.17
Nociception, Pain, Negative Moods, and Behavior Selection. Neuron (2015) 1.17
The ever-changing brain: cellular and molecular mechanisms for the effects of stressful experiences. Dev Neurobiol (2012) 1.15
Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol Psychiatry (2009) 1.14
Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl) (2011) 1.12
Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations. Dev Psychopathol (2008) 1.10
Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology (2010) 1.10
Human biomarkers of rapid antidepressant effects. Biol Psychiatry (2013) 1.09
Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci (2006) 1.06
Suicide and suicidal behaviour. Lancet (2015) 1.03
Recognizing Resilience: Learning from the Effects of Stress on the Brain. Neurobiol Stress (2015) 1.03
Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology (2011) 1.02
The molecular bases of the suicidal brain. Nat Rev Neurosci (2014) 1.02
Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression. Behav Brain Res (2011) 1.01
The prefrontal cortex communicates with the amygdala to impair learning after acute stress in females but not in males. J Neurosci (2010) 1.01
Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology (2010) 1.00
Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder. PLoS One (2012) 0.99
Regional increases of cortical thickness in untreated, first-episode major depressive disorder. Transl Psychiatry (2014) 0.98
Neuron density and serotonin receptor binding in prefrontal cortex in suicide. Int J Neuropsychopharmacol (2011) 0.97
Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacology (Berl) (2010) 0.97
Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia. Neuropsychopharmacology (2012) 0.97
The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord (2009) 0.96
Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice. Neuropsychopharmacology (2014) 0.96
Serum S100B represents a new biomarker for mood disorders. Curr Drug Targets (2013) 0.94
Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb Cortex (2008) 0.94
Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatr Dis Treat (2008) 0.94
Low nNOS protein in the locus coeruleus in major depression. J Neurochem (2004) 0.94
The impact of vascular burden on late-life depression. Brain Res Rev (2009) 0.94
Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol (2010) 0.93
Mood stabilizer psychopharmacology. Clin Neurosci Res (2002) 0.93
Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci (2012) 0.93
Reduced hippocampal volume in drug-free depressed patients. Surg Radiol Anat (2006) 0.93
Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci (2013) 0.92
Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochem Res (2008) 0.92
Structural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic disorders related to depression. Dialogues Clin Neurosci (2004) 0.90
Validation of the isotropic fractionator: comparison with unbiased stereology and DNA extraction for quantification of glial cells. J Neurosci Methods (2013) 0.90
Mood-stabilizers target the brain arachidonic acid cascade. Curr Mol Pharmacol (2009) 0.89
The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study. Behav Brain Res (2012) 0.89
Synaptic regulation of affective behaviors; role of BDNF. Neuropharmacology (2013) 0.89
Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry. Ann Gen Psychiatry (2008) 0.89
The neurobiology of treatment response to antidepressants and mood stabilizing medications. J Psychiatry Neurosci (2002) 0.89
Effects of mood stabilizers on DNA damage in an animal model of mania. J Psychiatry Neurosci (2008) 0.88
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berl) (2003) 0.88
Differentiating patterns of amygdala-frontal functional connectivity in schizophrenia and bipolar disorder. Schizophr Bull (2013) 0.88
Long-term effects of maternal immune activation on depression-like behavior in the mouse. Transl Psychiatry (2014) 0.88
First-episode medication-naive major depressive disorder is associated with altered resting brain function in the affective network. PLoS One (2014) 0.87
Comparison of prefrontal cell pathology between depression and alcohol dependence. J Psychiatr Res (2003) 0.87
Biophysical modeling of high field diffusion MRI demonstrates micro-structural aberration in chronic mild stress rat brain. Neuroimage (2016) 0.87
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatr Scand (2012) 0.87
Structural neuroimaging of geriatric depression. Psychiatr Clin North Am (2011) 0.87
Effects of chronic stress on prefrontal cortex transcriptome in mice displaying different genetic backgrounds. J Mol Neurosci (2012) 0.86
Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application. Transl Psychiatry (2014) 0.86
The GABAβ receptor as a target for antidepressant drug action. Br J Pharmacol (2011) 0.86
GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Invest (2016) 0.85
Effects of neonatal flutamide treatment on hippocampal neurogenesis and synaptogenesis correlate with depression-like behaviors in preadolescent male rats. Neuroscience (2010) 0.85
Frontal-subcortical volumetric deficits in single episode, medication-naïve depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study. PLoS One (2014) 0.84
Biological substrates underpinning diagnosis of major depression. Int J Neuropsychopharmacol (2013) 0.84
Full remission: a return to normal functioning. J Psychiatry Neurosci (2002) 0.84
The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. Bipolar Disord (2010) 0.83
The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting. J Comp Neurol (2016) 0.83
The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression. J Neural Transm (Vienna) (2008) 0.82
Effects of mental illness and aging in two thalamic nuclei. Schizophr Res (2008) 0.82
Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor. Int J Mol Sci (2010) 0.81
Cellular plasticity and resilience and the pathophysiology of severe mood disorders. Dialogues Clin Neurosci (2004) 0.81
Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates. Transl Psychiatry (2014) 0.81
Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression. J Psychiatr Res (2014) 0.80
Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder. Front Cell Neurosci (2015) 0.80
Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience. Int J Geriatr Psychiatry (2008) 0.80
Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability. Cell Mol Neurobiol (2014) 0.79
Neural markers of familial risk for depression: An investigation of cortical thickness abnormalities in healthy adolescent daughters of mothers with recurrent depression. J Abnorm Psychol (2015) 0.79
Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight. Neuroimage Clin (2014) 0.79
Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care. Neuropsychiatry (London) (2013) 0.78